{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:18:55Z","timestamp":1781939935042,"version":"3.54.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T00:00:00Z","timestamp":1682726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T00:00:00Z","timestamp":1682726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Royal Library, Copenhagen University Library"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Monit Comput"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Purpose: The neuromuscular blocking agent rocuronium can be administered to facilitate tracheal intubation. We hypothesized that rocuronium 0.9\u00a0mg\/kg provided a larger proportion of patients with vocal cords in abducted position compared to rocuronium 0.6\u00a0mg\/kg at train-of-four (TOF) 0. Methods: This secondary analysis was based on 52 elderly surgical patients of which 36 patients received rocuronium 0.6\u00a0mg\/kg and 16 patients received rocuronium 0.9\u00a0mg\/kg. Neuromuscular block was monitored with acceleromyography with TOF stimulation at the ulnar nerve. The primary outcome was the proportion of patients with vocal cords in abducted position at TOF 0. Secondary outcomes were intubating conditions evaluated by the Fuchs-Buder scale, the Intubating Difficulty Score (IDS), onset time, and duration of action of rocuronium. Results: At TOF 0, a significantly larger proportion of patients had vocal cords in abducted position in the rocuronium 0.9\u00a0mg\/kg group (81%) compared with the rocuronium 0.6\u00a0mg\/kg group (53%); difference (%) 28, 95% Cl 3\u201353, P\u2009=\u20090.05. Excellent intubating conditions (Fuchs-Buder) were more common in the rocuronium 0.9\u00a0mg\/kg group (62.5%); difference (%) 32.5, 95% Cl 4\u201361), P\u2009=\u20090.03. No significant difference was found in IDS or onset time of rocuronium (difference 19\u00a0s, 95% Cl: -5\u201343). Duration of action was significantly longer (difference 29\u00a0min, 95% Cl: 10\u201347) in the 0.9\u00a0mg\/kg group. Conclusion: The proportion of patients with vocal cords in abducted position was significantly larger after rocuronium 0.9\u00a0mg\/kg compared to rocuronium 0.6\u00a0mg\/kg at TOF 0 monitored at the ulnar nerve.<\/jats:p>","DOI":"10.1007\/s10877-023-01012-6","type":"journal-article","created":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T06:02:14Z","timestamp":1682748134000},"page":"1045-1050","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Tracheal intubating conditions in elderly patients when train-of-four count is zero after rocuronium 0.6 or 0.9\u00a0mg\/kg. A secondary analysis"],"prefix":"10.1007","volume":"37","author":[{"given":"Matias","family":"Vested","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mian","family":"Hartoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars S","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,29]]},"reference":[{"key":"1012_CR1","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.bja.2017.11.106","volume":"120","author":"LH Lundstr\u00f8m","year":"2018","unstructured":"Lundstr\u00f8m LH, Duez CH, N\u00f8rskov AK, Rosenstock CV, Thomsen JL, M\u00f8ller AM, Strande S, Wetterslev J. Effects of avoidance or use of neuromuscular blocking agents on outcomes in tracheal intubation: a Cochrane systematic review. Br J Anaesth. 2018;120:1381\u201393. https:\/\/doi.org\/10.1016\/j.bja.2017.11.106.","journal-title":"Br J Anaesth"},{"key":"1012_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-2253-14-39","volume":"14","author":"T Mencke","year":"2014","unstructured":"Mencke T, Jacobs RM, Machmueller S, Sauer M, Heidecke C, Kallert A, Pau HW, Noeldge-Schomburg G, Ovari A. Intubating conditions and side effects of propofol, remifentanil and sevoflurane compared with propofol, remifentanil and rocuronium: a randomised, prospective, clinical trial. BMC Anesthesiol. 2014;14:39. https:\/\/doi.org\/10.1186\/1471-2253-14-39.","journal-title":"BMC Anesthesiol"},{"key":"1012_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/j.1399-6576.2007.01352.x","volume":"51","author":"T Fuchs-Buder","year":"2007","unstructured":"Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J. International Neuromuscular Meeting. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand. 2007;51:789\u2013808. https:\/\/doi.org\/10.1111\/j.1399-6576.2007.01352.x. 8.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1012_CR4","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/BF03019373","volume":"50","author":"TM Hemmerling","year":"2003","unstructured":"Hemmerling TM, Donati F. Neuromuscular blockade at the larynx, the diaphragm and the corrugator supercilii muscle: a review. Can J Anaesth. 2003;50:779\u201394. https:\/\/doi.org\/10.1007\/BF03019373.","journal-title":"Can J Anaesth"},{"key":"1012_CR5","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1097\/00000542-199011000-00013","volume":"73","author":"F Donati","year":"1990","unstructured":"Donati F, Meistelman C, Plaud B. Vecuronium neuromuscular blockade at the diaphragm, the orbicularis oculi, and adductor pollicis muscles. Anesthesiology. 1990;73:870\u20135. https:\/\/doi.org\/10.1097\/00000542-199011000-00013.","journal-title":"Anesthesiology"},{"key":"1012_CR6","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/BF03008227","volume":"39","author":"C Meistelman","year":"1992","unstructured":"Meistelman C, Plaud B, Donati F. Rocuronium (ORG 9426) neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis in humans. Can J Anaesth. 1992;39:665\u20139. https:\/\/doi.org\/10.1007\/BF03008227.","journal-title":"Can J Anaesth"},{"key":"1012_CR7","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/aas.13645","volume":"64","author":"C Bjerring","year":"2020","unstructured":"Bjerring C, Vested M, Arleth T, Eriksen K, Albrechtsen C, Rasmussen LS. Onset time and duration of action of rocuronium 0.6\u00a0mg\/kg in patients above 80 years of age: a comparison with young adults. Acta Anaesthesiol Scand. 2020;64:1082\u20138. https:\/\/doi.org\/10.1111\/aas.13645.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1012_CR8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/aas.14097","volume":"66","author":"M Vested","year":"2022","unstructured":"Vested M, Pape P, Kristensen CM, Dinesen F, Vang M, Christensen RE, Lindahl CB, Albrechtsen C, Rasmussen LS. Rocuronium 0.3 or 0.9\u00a0mg\/kg comparing onset time, duration of action, and intubating conditions in patients 80 years and older: a randomized study. Acta Anaesthesiol Scand. 2022;66:811\u20137. https:\/\/doi.org\/10.1111\/aas.14097.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1012_CR9","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1111\/AAS.13957","volume":"65","author":"M Vested","year":"2021","unstructured":"Vested M, S\u00f8rensen AM, Bjerring C, Christensen RE, Dinesen F, Vang M, Gilvanoff A, Hansen TE, Nielsen T, Rasmussen LS. A blinded randomised study comparing intubating conditions after either rocuronium 0.6\u00a0mg kg -1 or remifentanil 2 \u00b5g kg -1 in elderly patients. Acta Anaesthesiol Scand. 2021;65:1367\u201373. https:\/\/doi.org\/10.1111\/AAS.13957.","journal-title":"Acta Anaesthesiol Scand"},{"key":"1012_CR10","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1097\/00000542-199712000-00005","volume":"87","author":"F Adnet","year":"1997","unstructured":"Adnet F, Borron SW, Racine SX, Clemessy JL, Fournier JL, Plaisance P, Lapandry C. The intubation difficulty scale (IDS): proposal and evaluation of a new score characterizing the complexity of endotracheal intubation. Anesthesiology. 1997;87:1290\u20137. https:\/\/doi.org\/10.1097\/00000542-199712000-00005.","journal-title":"Anesthesiology"},{"key":"1012_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.4103\/1658-354X.177330","volume":"10","author":"SG Chavan","year":"2016","unstructured":"Chavan SG, Gangadharan S, Gopakumar AK. Comparison of rocuronium at two different doses and succinylcholine for tracheal intubation in adult patients for elective surgeries. Saudi J Anaesth. 2016;10:379\u201383. https:\/\/doi.org\/10.4103\/1658-354X.177330.","journal-title":"Saudi J Anaesth"},{"key":"1012_CR12","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1097\/00000542-200305000-00005","volume":"98","author":"T Mencke","year":"2003","unstructured":"Mencke T, Echternach M, Kleinschmidt S, Lux P, Barth V, Plinkert PK, Fuchs-Buder T. Laryngeal morbidity and quality of tracheal intubation: a randomized controlled trial. Anesthesiology. 2003;98:1049\u201356. https:\/\/doi.org\/10.1097\/00000542-200305000-00005.","journal-title":"Anesthesiology"},{"key":"1012_CR13","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s00540-020-02831-6","volume":"34","author":"S Takagi","year":"2020","unstructured":"Takagi S, Sugaya N, Kiuchi N, Iwasa A, Itagaki M, Seki A, Suzuki J, Suzuki T. High-dose rocuronium-induced paralysis of the adductor pollicis muscle facilitates detection of the timing for tracheal intubation in elderly patients: a randomized double-blind study. J Anesth. 2020;34:876\u201380. https:\/\/doi.org\/10.1007\/s00540-020-02831-6.","journal-title":"J Anesth"},{"key":"1012_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/00000542-200107000-00019","volume":"95","author":"B Plaud","year":"2001","unstructured":"Plaud B, Debaene B, Donati F. The corrugator supercilii, not the orbicularis oculi, reflects rocuronium neuromuscular blockade at the laryngeal adductor muscles. Anesthesiology. 2001;95:96\u2013101. https:\/\/doi.org\/10.1097\/00000542-200107000-00019.","journal-title":"Anesthesiology"}],"container-title":["Journal of Clinical Monitoring and Computing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10877-023-01012-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10877-023-01012-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10877-023-01012-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T21:55:45Z","timestamp":1693518945000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10877-023-01012-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,29]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1012"],"URL":"https:\/\/doi.org\/10.1007\/s10877-023-01012-6","relation":{},"ISSN":["1387-1307","1573-2614"],"issn-type":[{"value":"1387-1307","type":"print"},{"value":"1573-2614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,29]]},"assertion":[{"value":"31 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MH and LSR declare they have no financial interests. MV has received speaker fees and research funding from Merck.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This study was a secondary analysis of data from two randomized studies and one observational study. The randomized studies were approved by the Danish Medicines Agency and the Scientific Ethics Committee. The protocol for the observational study was submitted to the Danish Medicines Agency and the Ethics Committee, who decided that no formal approval was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"A secondary analysis of three trials: NCT04287426, NCT04512313, NCT03857750.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Trial registration number"}}]}}